GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.
Perhaps the MM's are gauging our metal to see how friable we are.
Stand firm and support our new bag holders.
If we hit 4.5 as per 2018, then copper roof for me .. :)
I've only just had it re-felted.
"Warning ....! Imminent Danger of Making a Profit".
HOLD ...!
Incredible turnaround from March 2019. A * GMR.
Would not be surprised to see a future listing on the NASDAQ, which would do them no harm.
Well done, you've moved the dial.
We have the confectionary, just needs to be displayed more enticingly to all of those new ISA investors.
Someone mistaken us for Ascential again ?
The only aspect of your production that Roger may take issue with, is the fact that you didn't buy your Cider from him. Apart from that, I think he would approve. Sounds very tasty and something I must make an effort to try this year (Don't worry Roger, I'll still be buying from Somerset's finest). As for Merc's share price, the PR machine needs to replicate the later half of last years efforts and maintain the positive news flow IMHO. ...And here's to versatility Katy, our friend and matey...!
Potato ??
And in the mean time ........ Place your bets...!
The cytokine storm and hyperinflammation resulting in severe lung damage, followed by respiratory failure are the main underlying reasons for morbidity and mortality in COVID-19 patients (1). Recent clinical evidence suggests that the level of peripheral Tregs is prominently reduced in severely ill COVID-19 patients (2). The clinical data from a recently completed clinical study indicated that the nasal administration of Foralumab stimulated production of Tregs in healthy volunteers (https://www.tizianalifesciences.com/news-item?s=2019-09-10-tiziana-reports-phase-1-clinical-data-demonstrating-nasal-treatment-with-foralumab-was-well-tolerated-and-produced-positive-trend-in-biomarkers-of-immunomodulation-and-anti-inflammation-in-healthy-volunteers), suggesting that nasal treatment with Foralumab might improve clinical outcome by stimulating Tregs in patients. This is a highly innovative approach, which could also be useful for treatment of patients with Middle Eastern Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS-CoV-1), COVID-19 and Acute Respiratory Distress Syndrome (ARDS) because depletion of functional Tregs are commonly observed in these diseases.
NASDAQ now moving up :)
PS. Good spot 0161
I did watch the BBC series 6 : 1 inside the factory ref. cider making and could only imagine Rodger Wilkins shouting profanities at his TV. For someone or something to turn his precious apples into a sticky syrup would be a sacrilege beyond compare. On the other hand, he may have seen it as pure comedy, while sitting back supping his own magical unadulterated cider.
PS. I thought Katy apples were eaters ?
@Bluebelly - Thanks for that summary.
0161 - Apologies, yes I now follow your train of thought. And I like it.
Makes very good sense and I shell investigate further.
0161 - if your referring to Ex dividend date, then currently there isn't a dividend.
Interesting NASDAQ response. The usual pull back after initial rise and decent volume shows the awareness.
NASDAQ should start moving up as people calculate what the lowest price may be for the race to the results.
A *